BELATIR Trademark

Trademark Overview

On Friday, March 6, 2009, a trademark application was filed for BELATIR with the United States Patent and Trademark Office. The USPTO has given the BELATIR trademark a serial number of 77685367. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, November 8, 2019. This trademark is owned by Glaxo Group Limited. The BELATIR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines
belatir

General Information

Serial Number77685367
Word MarkBELATIR
Filing DateFriday, March 6, 2009
Status710 - CANCELLED - SECTION 8
Status DateFriday, November 8, 2019
Registration Number4310946
Registration DateTuesday, April 2, 2013
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 8, 2009

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, November 8, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Friday, November 8, 2019CANCELLED SEC. 8 (6-YR)
Monday, April 2, 2018COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, June 22, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 2, 2013REGISTERED-PRINCIPAL REGISTER
Wednesday, March 20, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 20, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, March 15, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 15, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, February 21, 20131(B) BASIS DELETED; PROCEED TO REGISTRATION
Thursday, January 24, 2013NOTICE OF ALLOWANCE CANCELLED
Thursday, January 24, 2013TEAS DELETE 1(B) BASIS RECEIVED
Friday, August 31, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 30, 2012EXTENSION 5 GRANTED
Monday, August 27, 2012EXTENSION 5 FILED
Monday, August 27, 2012TEAS EXTENSION RECEIVED
Saturday, February 11, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 10, 2012EXTENSION 4 GRANTED
Wednesday, February 8, 2012EXTENSION 4 FILED
Wednesday, February 8, 2012TEAS EXTENSION RECEIVED
Tuesday, August 9, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 8, 2011EXTENSION 3 GRANTED
Monday, August 1, 2011EXTENSION 3 FILED
Monday, August 1, 2011TEAS EXTENSION RECEIVED
Saturday, February 5, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 4, 2011EXTENSION 2 GRANTED
Thursday, January 13, 2011EXTENSION 2 FILED
Friday, February 4, 2011CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, January 13, 2011TEAS EXTENSION RECEIVED
Saturday, August 21, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 19, 2010EXTENSION 1 GRANTED
Thursday, August 19, 2010EXTENSION 1 FILED
Thursday, August 19, 2010TEAS EXTENSION RECEIVED
Thursday, May 13, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 2, 2010NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 8, 2009OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 8, 2009PUBLISHED FOR OPPOSITION
Thursday, November 5, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, November 3, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 3, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, November 3, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 3, 2009ASSIGNED TO LIE
Saturday, October 24, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, October 22, 2009TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, May 22, 2009NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, May 22, 2009NON-FINAL ACTION E-MAILED
Friday, May 22, 2009NON-FINAL ACTION WRITTEN
Thursday, May 14, 2009ASSIGNED TO EXAMINER
Tuesday, March 10, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, March 10, 2009NEW APPLICATION ENTERED IN TRAM

Related Keywords

belatir pharmaceutical treatment substances disorders preparations diseases hormonal neurological gastrointestinal ophthalmic